Benzinga
Benzinga
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Benzinga
vendredi, octobre 23
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Pomdoctor Ltd
POM
NASDAQ
Liste de surveillance
Get Report
Trade with Public
Get Report
Trade with Public
$2.03
-0.98
-32.56%
Dern. MÀJ: Oct 22, 7:59 PM
$1.91
-1.10
-36.42%
Get Report
Aperçu
Actualités
Prévisions de résultats
Événements
Données financières
Sentiment
Comparer
Rapport sur les stocks
Privacy Manager
Pomdoctor Financials
Pomdoctor (POM) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
Nasdaq Down 400 Points; Tesla Shares Fall After Q3 Results
US stocks fell, led by Nasdaq’s 1.54% drop. Tesla slid 2% despite an earnings beat; oil rose, while gold and Asian markets declined.
Avi Kapoor
Goodyear Tire, Cryo-Cell International and 3 Stocks to Watch Heading Into Monday
Goodyear names Joe Hinrichs chair, Pomdoctor faces Nasdaq delisting; Cryo-Cell earnings rise; SMP and Quantum announce CFO changes.
Avi Kapoor
PRO
Pomdoctor FY EPS $(3.14), Sales $57.187M
Pomdoctor (NASDAQ:POM) reported quarterly losses of $(3.14) per share. The company reported $57.187 million in sales this quarter.
Benzinga Newsdesk
Crude Oil Moves Lower; Photronics Shares Surge After Q4 Results
Avi Kapoor
US Stocks Mixed Ahead Of Fed Decision; Dow Surges 100 Points
Avi Kapoor
PRO
Pomdoctor H1 EPS $(1.60), Sales $24.400M
Pomdoctor (NASDAQ:POM) reported quarterly losses of $(1.60) per share. The company reported $24.400 million in sales this quarter.
Benzinga Newsdesk
